Dingal, Prince Jay P.

HRN: 21-39-22  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/28/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
05/28/2023
06/04/2023
IV DRIP
900mg
Q8
PCAP-C
Checking Final Appropriateness 
05/28/2023
MUPIROCIN 2%, 15G (TUBE)
05/28/2023
06/04/2023
TOPICAL
1g
TID
Cellulitis
Checking Final Appropriateness 
05/30/2023
CEFIXIME 100MG/5ML, 60ML SUSPENSION (BOT)
05/30/2023
06/06/2023
ORAL
2ml
Bid
Pcap C
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: